Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study
Status:
Completed
Trial end date:
2020-03-19
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the pharmacokinetic (PK) profiles of ciprofloxacin or
doxycycline when administered orally, prior to, and following, the intramuscular (IM)
administration of a two-dose schedule of AV7909 administered two weeks apart.
Phase:
Phase 2
Details
Lead Sponsor:
Emergent BioSolutions Emergent Product Development Gaithersburg, Inc.
Collaborator:
Biomedical Advanced Research and Development Authority